Major Bank Rating | Baird: Initiates Abbott with an "Outperform" rating and a target price of $121

格隆汇2026/07/03 03:26

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Glonghui, July 3 — Baird has initiated research coverage of Abbott Laboratories, giving it an “Outperform” rating and setting a target price of $121. According to Baird, this diversified healthcare company is likely to achieve stronger earnings growth thanks to its broad product portfolio and upcoming product launches, despite facing some short-term headwinds.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Major Bank Rating | Baird: Initiates Abbott with an "Outperform" rating and a target price of $121

You may also like

Crypto prices